Investigate the Efficacy and Safety of Farudodstat Compared With Its Placebo in Adult Alopecia Areata Participants
Clinical trial NCT05865041 · UNKNOWN
Trial details
- NCT number
- NCT05865041
- Sponsor
- ASLAN Pharmaceuticals
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-04-14
- Primary completion
- 2024-09-12
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.